David C. Myles, CHIEF DEVELOPMENT OFFICER at Olema Pharmaceuticals, Inc. (OLMA), sold 10,000 shares at $10.30 ($103K) on 2021-12-10, disclosed to the SEC on 2021-12-14.
Open-market sale of $103k OLMA by CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OLMA | SELL | 2024-12-11 | $467K | — | Filing → |
| OLMA | SELL | 2023-11-22 | $389K | — | Filing → |
| OLMA | SELL | 2023-11-13 | $4K | — | Filing → |